KILITCH DRUGS (INDIA)
Quarterly Results Analysis [Sep2025]
KILITCH DRUGS (INDIA) Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹49 Cr | ₹43 Cr | ₹61 Cr | ₹56 Cr | ₹47 Cr | ₹33 Cr | ₹45 Cr | ₹32 Cr |
| Expenses | ₹44 Cr | ₹40 Cr | ₹47 Cr | ₹47 Cr | ₹41 Cr | ₹32 Cr | ₹38 Cr | ₹30 Cr |
| Operating Income | ₹5 Cr | ₹3 Cr | ₹15 Cr | ₹9 Cr | ₹6 Cr | ₹2 Cr | ₹7 Cr | ₹2 Cr |
| Other Income | ₹7 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹5 Cr | ₹3 Cr | ₹0 Cr | ₹3 Cr |
| Interest | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹0 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
| Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Profit Before Tax | ₹9 Cr | ₹3 Cr | ₹14 Cr | ₹8 Cr | ₹10 Cr | ₹2 Cr | ₹5 Cr | ₹3 Cr |
| Profit After Tax | ₹8 Cr | ₹2 Cr | ₹10 Cr | ₹6 Cr | ₹9 Cr | ₹0 Cr | ₹4 Cr | ₹2 Cr |
| EPS | ₹4.69 | ₹1.84 | ₹6.33 | ₹3.63 | ₹5.36 | ₹0.82 | ₹2.19 | ₹1.77 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| KILITCH DRUGS (INDIA) | 2.2% | -2.2% | 10.5% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.5% | -1.9% | -3% |
| DIVIS LABORATORIES | 1.8% | 1.3% | 10.8% |
| CIPLA | -0.2% | -0.7% | 1.9% |
| TORRENT PHARMACEUTICALS | 2% | 2.4% | 11.2% |
| DR REDDYS LABORATORIES | -1% | 2.5% | -4.4% |
| MANKIND PHARMA | 2.4% | -2.2% | -20.4% |
| ZYDUS LIFESCIENCES | 0.4% | -1.1% | -4.7% |
| LUPIN | -0.4% | 3.2% | -1.6% |
KILITCH DRUGS (INDIA) Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 13.41 % |
| Y-o-Y | 3.05 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹49 Cr | 13.41 | |
| Jun2025 | ₹43 Cr | -29.54 | |
| Mar2025 | ₹61 Cr | 9.01 | |
| Dec2024 | ₹56 Cr | 18.31 | |
| Sep2024 | ₹47 Cr | 41.92 | |
| Jun2024 | ₹33 Cr | -25.36 | |
| Mar2024 | ₹45 Cr | 40.97 | |
| Dec2023 | ₹32 Cr | - | |
KILITCH DRUGS (INDIA) Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 54.41 % |
| Y-o-Y | -17.28 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹5 Cr | 54.41 | |
| Jun2025 | ₹3 Cr | -77.63 | |
| Mar2025 | ₹15 Cr | 67.07 | |
| Dec2024 | ₹9 Cr | 43.36 | |
| Sep2024 | ₹6 Cr | 267.05 | |
| Jun2024 | ₹2 Cr | -76.55 | |
| Mar2024 | ₹7 Cr | 210.57 | |
| Dec2023 | ₹2 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 36.06 % |
| Y-o-Y | -19.72 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 10.3% | 36.06 | |
| Jun2025 | 7.57% | -68.25 | |
| Mar2025 | 23.84% | 53.31 | |
| Dec2024 | 15.55% | 21.20 | |
| Sep2024 | 12.83% | 158.67 | |
| Jun2024 | 4.96% | -68.59 | |
| Mar2024 | 15.79% | 120.22 | |
| Dec2023 | 7.17% | - | |
KILITCH DRUGS (INDIA) Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 255.55 % |
| Y-o-Y | -6.64 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹8 Cr | 255.55 | |
| Jun2025 | ₹2 Cr | -77.87 | |
| Mar2025 | ₹10 Cr | 82.06 | |
| Dec2024 | ₹6 Cr | -34.82 | |
| Sep2024 | ₹9 Cr | 7,588.39 | |
| Jun2024 | ₹0 Cr | -96.96 | |
| Mar2024 | ₹4 Cr | 111.49 | |
| Dec2023 | ₹2 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 213.55 % |
| Y-o-Y | -9.43 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 16.43 % | 213.55 | |
| Jun2025 | 5.24 % | -68.60 | |
| Mar2025 | 16.69 % | 67.07 | |
| Dec2024 | 9.99 % | -44.93 | |
| Sep2024 | 18.14 % | 5,396.97 | |
| Jun2024 | 0.33 % | -95.99 | |
| Mar2024 | 8.22 % | 50.00 | |
| Dec2023 | 5.48 % | - | |
KILITCH DRUGS (INDIA) Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 154.89 % |
| Y-o-Y | -12.50 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹4.69 | 154.89 | |
| Jun2025 | ₹1.84 | -70.93 | |
| Mar2025 | ₹6.33 | 74.38 | |
| Dec2024 | ₹3.63 | -32.28 | |
| Sep2024 | ₹5.36 | 553.66 | |
| Jun2024 | ₹0.82 | -62.56 | |
| Mar2024 | ₹2.19 | 23.73 | |
| Dec2023 | ₹1.77 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD